Search Results

Containing any of the words

Only of the type

(SG-2201-379-H) Identified risk linked to the use of Per-Fluor-Carbon-Octane liquids in ophthalmic surgery Medical Report

(SG-2208-394-H) Risk of Decreased flow rate, stopped flow or residual fluid left within the IV bag Medical Report

SFDA: “ E129 & E110 Colours are allowed to be used, with a statement advising that they may affect Children” Warnings

(SG-2010-275-H) Software issues for the Infinity Acute Care System (IACS) and Standalone Infinity M540 patient monitor Medical Report

"Comparison of IV ketamine with Standard Analgesia for treatment of vaso occlusive crisis in sickle cell disease." Drug Clinical Trial

D. alkanhal: Monitoring Food Sector Foreign Workers is a Big Challenge to the SFDA News

The SFDA Organizes a Workshop to Discuss the Draft of Medical Devices and Products Monitoring System News

"SFDA" to take measures to ensure the availability of asthma and respiratory diseases treatment News

How to obtain the results of a technical visit to an external monitoring facility or authority? FAQ

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment Drug Clinical Trial